Phio Pharmaceuticals Corp. (PHIO) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 17.4M | 21.48M | 11.49M | 11.29M | 13.44M | 5.74M | 5.86M | 5.29M | 6.85M | 9.32M | 9.33M | 12.04M |
| Cash & Short-Term Investments | 17.03M | 21.03M | 10.71M | 10.78M | 13.28M | 5.38M | 5.39M | 4.7M | 6.47M | 8.49M | 8.41M | 11.31M |
| Cash Only | 17.03M | 21.03M | 10.71M | 10.78M | 13.28M | 5.38M | 5.39M | 4.7M | 6.47M | 8.49M | 8.41M | 11.31M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 371K | 445K | 788K | 519K | 158K | 354K | 474K | 594K | 373K | 832K | 50K | 50K |
| Total Non-Current Assets | 10K | 11K | 12K | 7K | 4K | 2K | 1K | 4K | 5K | 42K | 211K | 261K |
| Property, Plant & Equipment | 10K | 11K | 12K | 7K | 4K | 2K | 1K | 1K | 2K | 39K | 208K | 255K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3K | 3K | 3K | 3K | 6K |
| Total Assets | 17.41M | 21.49M | 11.51M | 11.3M | 13.44M | 5.74M | 5.87M | 5.3M | 6.85M | 9.36M | 9.54M | 12.3M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 29.55% | 274.47% | 96.16% | 113.39% | 96.12% | -38.72% | -38.52% | -56.93% | -29.4% | -26.92% | -39.59% | -38.96% |
| Total Current Liabilities | 260K | 435K | 516K | 1.21M | 1.27M | 1.01M | 919K | 1.52M | 1.25M | 1.63M | 2.33M | 2.39M |
| Accounts Payable | 260K | 435K | 516K | 235K | 427K | 253K | 184K | 335K | 320K | 657K | 173K | 641K |
| Days Payables Outstanding | 31.27K | - | - | 28.05 | - | - | 37.07 | 34.41 | - | 887.91 | 20.71 | 1.43K |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | -360K | -732K | 0 | 0 | 31K | 0 | 0 | 0 | 720K | 0 | 0 |
| Current Ratio | 66.93x | 49.37x | 22.27x | 9.36x | 10.58x | 5.65x | 6.38x | 3.47x | 5.48x | 5.71x | 4.01x | 5.03x |
| Quick Ratio | 66.93x | 49.37x | 22.27x | 9.36x | 10.58x | 5.65x | 6.38x | 3.47x | 5.48x | 5.71x | 4.01x | 5.03x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 690K | 905K | 1.15M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 690K | 905K | 1.15M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 950K | 1.34M | 1.67M | 1.21M | 1.27M | 1.01M | 919K | 1.52M | 1.25M | 1.63M | 2.33M | 2.39M |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35K | 70K | 104K |
| Net Debt | -17.03M | -21.03M | -10.71M | -10.78M | -13.28M | -5.38M | -5.39M | -4.7M | -6.47M | -8.46M | -8.34M | -11.2M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | 0.00x | 0.01x | 0.01x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 16.46M | 20.15M | 9.84M | 10.1M | 12.17M | 4.72M | 4.95M | 3.77M | 5.6M | 7.73M | 7.21M | 9.9M |
| Equity Growth % | 35.27% | 326.57% | 98.93% | 167.56% | 117.17% | -38.9% | -31.43% | -61.9% | -23.35% | -28.69% | -46.68% | -41.75% |
| Book Value per Share | 1.42 | 1.73 | 1.80 | 2.11 | 2.83 | 6.00 | 5.00 | 7.40 | 11.02 | 18.58 | 26.63 | 51.62 |
| Total Shareholders' Equity | 16.46M | 20.15M | 9.84M | 10.1M | 12.17M | 4.72M | 4.95M | 3.77M | 5.6M | 7.73M | 7.21M | 9.9M |
| Common Stock | 1K | 1K | 1K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | -159.06M | -155.05M | -152.68M | -150.29M | -148.13M | -146.36M | -144.73M | -143.21M | -141.36M | -139.21M | -137.31M | -134.53M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |